AI-Powered health coach in your pocket: could this app prevent disease?

NCT ID NCT07612852

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a digital platform called DELPHI that uses a wearable fitness tracker and smartphone app to give personalized lifestyle tips on exercise, sleep, diet, and stress. Researchers will enroll 200 healthy adults in southern Italy and randomly assign them to use either the full platform with AI recommendations or a basic version that only tracks data. The goal is to see if the platform is easy to use and acceptable, and whether it might help improve quality of life and reduce risk factors for chronic diseases.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

DELPHI Personalized Digital Prevention Platform (digital platform with wearable sensors and AI recommendations)

What this could lead to

If successful, this could provide a scalable, personalized digital tool to help healthy adults adopt and maintain healthier lifestyles, potentially reducing the risk of chronic diseases.

What could go wrong

This is an early pilot study with only 200 participants, focused on feasibility and usability, not on proving health outcomes. The results may not generalize to other populations or settings.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTH PROMOTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Risk Reduction Behavior

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • Institute for Biomedical Research and Innovation (IRIB)-National Reasearch Council (CNR)

    RECRUITING

    Messina, 98164, Italy

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact